AU2001282595A1 - Tetrahydrobenzindole derivatives capable of binding to 5-ht7 receptor and metabolically stable - Google Patents

Tetrahydrobenzindole derivatives capable of binding to 5-ht7 receptor and metabolically stable

Info

Publication number
AU2001282595A1
AU2001282595A1 AU2001282595A AU8259501A AU2001282595A1 AU 2001282595 A1 AU2001282595 A1 AU 2001282595A1 AU 2001282595 A AU2001282595 A AU 2001282595A AU 8259501 A AU8259501 A AU 8259501A AU 2001282595 A1 AU2001282595 A1 AU 2001282595A1
Authority
AU
Australia
Prior art keywords
receptor
binding
metabolically stable
derivatives capable
tetrahydrobenzindole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001282595A
Inventor
Kazuyuki Fuji
Toyokazu Hiranuma
Chika Kikuchi
Masao Koyama
Masayo Okuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Publication of AU2001282595A1 publication Critical patent/AU2001282595A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2001282595A 2000-08-31 2001-08-31 Tetrahydrobenzindole derivatives capable of binding to 5-ht7 receptor and metabolically stable Abandoned AU2001282595A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000262597A JP2004231514A (en) 2000-08-31 2000-08-31 Tetrahydrobenzindole derivative exhibiting binding ability to 5-ht7 receptor and metabolically stable
JP2000-262597 2000-08-31
PCT/JP2001/007573 WO2002018367A1 (en) 2000-08-31 2001-08-31 Tetrahydrobenzindole derivatives capable of binding to 5-ht7 receptor and metabolically stable

Publications (1)

Publication Number Publication Date
AU2001282595A1 true AU2001282595A1 (en) 2002-03-13

Family

ID=18750255

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001282595A Abandoned AU2001282595A1 (en) 2000-08-31 2001-08-31 Tetrahydrobenzindole derivatives capable of binding to 5-ht7 receptor and metabolically stable

Country Status (3)

Country Link
JP (1) JP2004231514A (en)
AU (1) AU2001282595A1 (en)
WO (1) WO2002018367A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215551A1 (en) * 2004-03-25 2005-09-29 Solvay Pharmaceuticals B.V. 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
AR049478A1 (en) 2004-03-25 2006-08-09 Solvay Pharm Bv A PROCEDURE FOR THE PREPARATION OF 3-AMINO-8- (1-PIPERAZINIL) -2H-1-BENZOPIRAN-2-ONA. SALTS AND HYDRATES AND PHARMACEUTICAL COMPOSITIONS.
EP1751134A1 (en) * 2004-05-11 2007-02-14 EGIS Gyógyszergyár Nyrt Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355642B1 (en) * 1996-06-28 2002-03-12 Meiji Seika Kaisha, Ltd. Tetrahydrobenzindole compounds
US6407112B1 (en) * 1998-04-22 2002-06-18 Meiji Seika Kaisha, Ltd. Optically active tetrahydrobenzindole derivative

Also Published As

Publication number Publication date
WO2002018367A1 (en) 2002-03-07
JP2004231514A (en) 2004-08-19

Similar Documents

Publication Publication Date Title
HK1048247A1 (en) Stable carotene-xanthophyll beadlet compositions and methods of use
HUP0200429A2 (en) Soluble receptor br43x2 and methods of using
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU7524601A (en) T cell receptor fusions and conjugates and methods of use thereof
HUP0301269A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
AU2001296799A1 (en) Benzimidazole and indole derivatives as crf receptor modulators
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2268401A (en) Novel succinate compounds, compositions and methods of use and preparation
AU4134101A (en) Hormone receptor functional entities and methods of their use
AU2001276440A1 (en) Use and cosmetic compositions of starch betainates
AU7358800A (en) Compositions and methods for modification of skin lipid content
AU2001289758A1 (en) Novel indole derivatives and their use as medicaments
AU6385800A (en) Archaeal replication accessory factors and methods of use
AP2001002371A0 (en) Streptogramin derivatives preparation and compositions containing them
HUP0104175A3 (en) Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
AU2001282595A1 (en) Tetrahydrobenzindole derivatives capable of binding to 5-ht7 receptor and metabolically stable
AU2002230781A1 (en) Pharmaceutical uses and synthesis of benzobicyclooctanes
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations
AUPQ570100A0 (en) Beta-alanine derivatives and their use as receptor antagonists
HK1048633A1 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
AU2002219176A1 (en) Dihydroindole and tetrahydroquinoline derivatives
AU4834101A (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem